Acorah Software Products - Accounts Production 16.1.300 false true 31 July 2023 8 July 2022 false true No description of principal activity 1 August 2023 31 July 2024 31 July 2024 14223755 Dr Rory Boud iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 14223755 2023-07-31 14223755 2024-07-31 14223755 2023-08-01 2024-07-31 14223755 frs-core:CurrentFinancialInstruments 2024-07-31 14223755 frs-bus:PrivateLimitedCompanyLtd 2023-08-01 2024-07-31 14223755 frs-bus:FilletedAccounts 2023-08-01 2024-07-31 14223755 frs-bus:Micro-entities 2023-08-01 2024-07-31 14223755 frs-bus:AuditExempt-NoAccountantsReport 2023-08-01 2024-07-31 14223755 frs-bus:Director1 2023-08-01 2024-07-31 14223755 2022-07-07 14223755 2023-07-31 14223755 2022-07-08 2023-07-31 14223755 frs-core:CurrentFinancialInstruments 2023-07-31
Registered number: 14223755
RKB Medical Limited
Unaudited Financial Statements
For The Year Ended 31 July 2024
Balance Sheet
Registered number: 14223755
31 July 2024 31 July 2023
£ £
Current assets 5,903 11,007
Creditors: Amounts Falling Due Within One Year (396 ) (5,180 )
NET CURRENT ASSETS 5,507 5,827
TOTAL ASSETS LESS CURRENT LIABILITIES 5,507 5,827
Accruals and deferred income (1,200 ) -
NET ASSETS 4,307 5,827
CAPITAL AND RESERVES 4,307 5,827

Notes

1. General Information
RKB Medical Limited is a private company, limited by shares, incorporated in England & Wales, registered number 14223755 . The registered office is Atelier House, 138b Parkstone Avenue , Poole, Dorset, BH14 9LS.
2. Average Number of Employees
Average number of employees, including directors, during the year was: 1 (2023: 1)
1 1
For the year ending 31 July 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Dr Rory Boud
Director
14 March 2025